Highlights
A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 81
» View wsbt.com items only
1
2
3
4
5
6
7
•
Next >
-
AstraZeneca pagará hasta 1.150 mln dlrs por Pearl
ReutersPor Ben Hirschler LONDRES (Reuters) - AstraZeneca comprará al especialista estadounidense en medicamentos respiratorios Pearl Therapeutics por hasta 1.150 millones de dólares, en un nuevo paso de la segunda más grande farmacéutica de Gran Bretaña en...Tags: GlaxoSmithKline PLC, AstraZeneca Plc, Seroquel (drug)
-
|Story
-
|Story
-
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
ReutersBy Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...Tags: University of Chicago, Politics, Boil (skin condition), Vanderbilt University , Elections
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Weather, Food and Drug Administration, Bristol Myers Squibb Company, Oncology, Amgen Inc.
-
Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: AstraZeneca Plc, GlaxoSmithKline PLC, Bristol Myers Squibb Company, Merck & Company Incorporated, Amgen Inc.
-
BUSINESS: Investors: Show me the stem cell money
Tribune staff reporterBig Pharma isn't yet convinced there will be a profit bonanza from stem cell therapy. If there will ever be blockbuster drugs from stem cell research--or cell therapies of any kind--the rewards in the lab aren't tickling the fancy of the world's...Tags: Diseases and Illnesses, Banking, Companies and Corporations, Agricultural Research and Technology, Medical Research
-
Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...Tags: Leukemia, Los Angeles Lakers, Lymphoma, Jimmy Kimmel, Kareem Abdul-Jabbar
-
Indian court ruling hailed as victory for generic drugs
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: U.S. Chamber of Commerce, Leukemia, India, Patents, Copyrights and Trademarks, Trade Dispute
-
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: Leukemia, Science and Technology, Health Treatments, India, Patents, Copyrights and Trademarks
-
10 Things to Know for Today
Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. TEXAS DA'S DEATH PUTS PROSECUTORS ON ALERT Law enforcement is beefing up security for Texas district attorneys after Mike McLelland and his wife...Tags: James Holmes
-
FDA approves first oral drug to slow multiple sclerosis progression
A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...Tags: Multiple Sclerosis, Health and Medical Professionals, Diseases and Illnesses, Human Body, Trials
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Jul 29, 2001
|Story| Chicago Tribune
Apr 12, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Los Angeles Times
Mar 31, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Aberdeen News
Sep 22, 2010
|Story| Los Angeles Times
Original site for Novartis AG topic gallery.